Health ❯ Cardiology ❯ Cardiovascular Health

Heart Disease

Youth Cardiac Issues Impact of Noise Pollution Cholesterol Management

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Merck plans to seek FDA review in early 2026 based on these Phase 3 lipid-lowering results.